Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today highlighted data presented at the American Association ...

Researchers grew crystals containing actinium and illuminated them with X-rays to learn how the radioactive metal binds with other elements. That information could help design better cancer treatments ...

Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today announced preclinical results for ATNM-400 across ...

After more than six years, Actinium is recording the much sought-after crackles of clinical connection in a phase 3 trial of its radiotherapy in older patients with leukemia. The company reported that ...

Opko Health OPK is perhaps most well known at this point for the near daily insider buying by its founder, CEO and Chairman Phillip Frost. A quick look at its insider transaction history paints quite ...

Actinium Pharmaceuticals Inc (AMEX:ATNM) shares are trading higher Tuesday after the company announced full data results from the pivotal Phase 3 SIERRA trial in patients with active, relapsed or ...

Oral presentation to highlight Iomab-B's ability to significantly improve overall survival in patients with relapsed or refractory AML with a TP53 mutation Four presentations in total demonstrating ...

NEW YORK, Oct. 9, 2012 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (API), a biopharmaceutical company that develops innovative targeted payload immunotherapeutics, announced that Johns Hopkins ...

FDA determined that the Phase 3 SIERRA trial is not adequate to support a BLA filing for Iomab-B despite its statistically significant primary endpoint Additional head-to-head randomized clinical ...

Actinium Adds Chief Executive Officer and Chief Financial Officer as Company Prepares for Public Listing of Stock NEW YORK, Aug. 23, 2012 -- /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (API), a ...

Radiotherapy is a staple among many medical interventions to treat cancer. Besides external beam radiotherapy and sealed radio-source therapy, it is common for oncologists to prescribe systemic ...

Actinium gains business development and investor relations expertise as well, as the Company raises its profile in the investment community. These four hires bring to the Company a robust and ...